Net profit of Bal Pharma declined 7.94% to Rs 1.16 crore in the quarter ended December 2024 as against Rs 1.26 crore during the previous quarter ended December 2023. Sales declined 10.55% to Rs 72.89 crore in the quarter ended December 2024 as against Rs 81.49 crore during the previous quarter ended December 2023.
| Particulars | Quarter Ended |
| Dec. 2024 | Dec. 2023 | % Var. |
| Sales | 72.89 | 81.49 | -11 |
| OPM % | 10.59 | 9.61 | - |
| PBDT | 3.53 | 4.23 | -17 |
| PBT | 1.20 | 1.68 | -29 |
| NP | 1.16 | 1.26 | -8 |